HSD17B13 and metabolic dysfunction-associated steatotic liver disease: HSD17B13 gene expression and protein levels are upregulated in patients and mouse models of MASLD and overexpression of Hsd17b13 in mice promotes rapid lipid accumulation in the liver (Su et al., 2014).